01
Financial Controls & Reporting
Core operating and reporting infrastructure rebuilt; finance, HR, and marketing controls institutionalized. Fixed cost base restructured toward a variable model.
A concentrated, control-oriented portfolio built one company at a time — anchored by a premium asset acquired through proprietary sourcing and now undergoing a hands-on operational transformation.
Founded in 2013, Lemonaid Health is an independent digital pharmacy, prescription-delivery, and telemedicine platform in the United States — acquired by Bambu Capital through a proprietary, court-supervised carve-out at a material discount to prior transaction value.
Lemonaid was previously acquired for $400M following a competitive process. During subsequent Chapter 11 proceedings of its parent, regulatory carve-out requirements created a forced sale of an otherwise strategic asset. Through a proprietary special-purpose vehicle, Bambu Capital secured exclusive access to acquire the platform at a materially discounted valuation relative to both the prior transaction and intrinsic value.
As part of the court-supervised process, the principals demonstrated transaction certainty and financial commitment by posting a substantial acquisition deposit, personally guaranteed. The transaction closed in December 2025, with the operational transition executed under budget and 100% continuity of patient appointments.
Digital health · telemedicine · digital pharmacy
Control investment via proprietary carve-out
Active — operational transformation underway
Core operating and reporting infrastructure rebuilt; finance, HR, and marketing controls institutionalized. Fixed cost base restructured toward a variable model.
Spend restructured with agency oversight, KPI controls, and AI-driven optimization; refocused on higher-margin service lines and strategic partnerships.
Workflow automation deployed across scheduling, refills, and support — expanding capacity without proportional headcount growth.
Portfolio-driven referral flow and employer access, reduced pharmacy procurement costs, and data-enabled care pathways increasing patient lifetime value.
Lemonaid demonstrates the core elements of the Bambu Capital model in a single transaction — and the fund launches with a premium operating asset rather than blind-pool risk.
Exclusive access to a strategic asset through a complex, court-supervised process.
Entry anchored to a disciplined, third-party reference point well below prior value.
Hands-on transformation from day one — the Bambu EDGE applied in practice.
We take control-oriented positions or structured minority stakes with board and protective control rights, then partner closely with management through a focused 12–18 month transformation.
The 8-Cylinder Audit establishes a prioritized, investment-specific value-creation roadmap before close.
The PROP Model deploys operators and centralizes finance, pricing, IT, and GTM that growth companies typically lack.
The Contribution Effect™ shares playbooks, talent, and networks across the portfolio to accelerate time-to-value.
Bambu Capital is actively advancing discussions across digital commerce, platform specialization, and product design — including a tech-enabled services commerce roll-up combining a platform company with complementary bolt-ons.
Read the roll-up thesis →Detailed portfolio performance and co-investment materials are available to qualified investors upon request.